Your browser is no longer supported. Please, upgrade your browser.
CPRX Catalyst Pharmaceuticals, Inc. daily Stock Chart
CPRX [NASD]
Catalyst Pharmaceuticals, Inc.
Index- P/E- EPS (ttm)-0.25 Insider Own5.40% Shs Outstand97.73M Perf Week12.15%
Market Cap270.71M Forward P/E- EPS next Y-0.15 Insider Trans2.43% Shs Float95.66M Perf Month6.95%
Income-24.90M PEG- EPS next Q-0.12 Inst Own50.10% Short Float6.88% Perf Quarter-3.48%
Sales- P/S- EPS this Y1.60% Inst Trans0.38% Short Ratio3.49 Perf Half Y-3.48%
Book/sh0.62 P/B4.47 EPS next Y51.60% ROA-32.50% Target Price8.17 Perf Year-20.17%
Cash/sh0.63 P/C4.39 EPS next 5Y- ROE-34.10% 52W Range1.85 - 4.05 Perf YTD44.27%
Dividend- P/FCF- EPS past 5Y-9.60% ROI- 52W High-31.60% Beta2.29
Dividend %- Quick Ratio18.00 Sales past 5Y- Gross Margin- 52W Low49.73% ATR0.13
Employees21 Current Ratio18.00 Sales Q/Q- Oper. Margin- RSI (14)64.10 Volatility4.65% 5.03%
OptionableYes Debt/Eq0.00 EPS Q/Q-55.00% Profit Margin- Rel Volume0.42 Prev Close2.71
ShortableYes LT Debt/Eq0.00 EarningsMar 13 AMC Payout- Avg Volume1.88M Price2.77
Recom- SMA2011.20% SMA5016.44% SMA200-6.87% Volume788,972 Change2.21%
Sep-21-18Initiated Cantor Fitzgerald Overweight
Sep-07-18Resumed Piper Jaffray Overweight
Oct-05-16Upgrade Piper Jaffray Neutral → Overweight
Apr-26-16Downgrade Piper Jaffray Overweight → Neutral $6 → $1
Sep-30-14Reiterated ROTH Capital Buy $5 → $6
Sep-16-14Reiterated ROTH Capital Buy $3.50 → $5
Sep-15-14Reiterated H.C. Wainwright Buy $5 → $13
Oct-21-13Reiterated Aegis Capital Buy $4 → $5.50
Sep-24-13Initiated Maxim Group Buy $4
Sep-06-13Reiterated Aegis Capital Buy $3.50 → $4
Apr-18-13Initiated Aegis Capital Buy $2.50
Aug-27-12Upgrade Rodman & Renshaw Mkt Perform → Mkt Outperform $3.70
Oct-01-09Upgrade Merriman Sell → Neutral
May-29-09Downgrade Merriman Curhan Ford Buy → Sell
May-29-09Downgrade Hapoalim Neutral → Underperform
Dec-15-08Initiated Merriman Curhan Ford Buy
Nov-28-07Initiated Rodman & Renshaw Mkt Outperform $9
Jan-31-07Initiated Stifel Nicolaus Buy $9
Jan-05-07Initiated First Albany Buy $10
Feb-11-19 02:58PM  Catalyst Pharma sees net price of drug, once free, topping $300,000 Reuters
Feb-06-19 02:39PM  Coral Gables company under fire for drug pricing says patient care is 'top priority' American City Business Journals
Feb-05-19 08:03AM  Catalyst Pharmaceuticals to Present at the 21st Annual BIO CEO & Investor Conference GlobeNewswire
Feb-04-19 10:34AM  U.S. Senator Sanders asks why drug, once free, now costs $375k Reuters -5.58%
06:00AM  U.S. Senator Sanders to ask why drug, once free, now costs $375k Reuters
Jan-28-19 12:22PM  What Kind Of Shareholders Own Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)? Simply Wall St.
Jan-04-19 08:03AM  Catalyst Pharmaceuticals Announces Publication of Clinical Data from the Investigator-Sponsored Phase IIb Study Evaluating Firdapse® for the Treatment of MuSK Antibody Positive Myasthenia Gravis GlobeNewswire +5.99%
Dec-19-18 12:32PM  Should You Buy Catalyst Pharmaceuticals, Inc. (CPRX)? Insider Monkey -7.82%
Dec-18-18 11:40AM  Catalyst Pharmaceuticals Announces Definitive Agreement with Endo for Vigabatrin Tablets GlobeNewswire
Dec-14-18 11:42AM  Does Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Have A Volatile Share Price? Simply Wall St.
Dec-11-18 07:30AM  Report: Exploring Fundamental Drivers Behind Sabre, Catalyst Pharmaceuticals, Renewable Energy Group, Luminex, Parker Drilling, and Apollo Endosurgery New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire +5.53%
Dec-03-18 08:03AM  Catalyst Pharmaceuticals Announces Conference Call to Discuss Commercialization Plan for Firdapse® (amifampridine) for Lambert-Eaton Myasthenic Syndrome (LEMS) GlobeNewswire -5.92%
Nov-30-18 05:42PM  Why Catalyst Pharmaceuticals Stock Fell Again Today Motley Fool -8.48%
Nov-29-18 04:00PM  Why Catalyst Pharmaceuticals Stock Is Sinking Today Motley Fool -11.50%
09:25AM  FDA approves new drug developed by Coral Gables company American City Business Journals
08:33AM  Catalyst's Firdapse Receives FDA Approval for Rare Disease Zacks
06:50AM  Today's Research Reports on Trending Tickers: Alliqua BioMedical and Catalyst Pharmaceuticals ACCESSWIRE
06:03AM  FDA Approves Firdapse® (amifampridine) for the Treatment of Lambert-Eaton Myasthenic Syndrome (LEMS) GlobeNewswire
Nov-28-18 06:36PM  U.S. FDA approves Catalyst Pharma's rare disease drug Reuters +7.56%
Nov-27-18 04:12PM  Catalyst Pharmaceuticals Announces Firdapse® (amifampridine) New Drug Application Continues Under Review GlobeNewswire
Nov-20-18 09:52PM  Edited Transcript of CPRX earnings conference call or presentation 8-Nov-18 1:30pm GMT Thomson Reuters StreetEvents -5.74%
08:39AM  Do Options Traders Know Something About Catalyst (CPRX) Stock We Don't? Zacks
Nov-07-18 06:35PM  Catalyst: 3Q Earnings Snapshot Associated Press
04:19PM  Catalyst Pharmaceuticals Announces Third Quarter 2018 Financial Results and Provides Corporate Update GlobeNewswire
Oct-31-18 08:03AM  Catalyst Pharmaceuticals to Hold Third Quarter Financial Results and Corporate Update Conference Call and Webcast on Thursday, November 8th, 2018 GlobeNewswire
Oct-10-18 07:30AM  Market Trends Toward New Normal in AllianceBernstein Holding, Five9, Simpson Manufacturing, Green Plains, Catalyst Pharmaceuticals, and Commercial Vehicle Group Emerging Consolidated Expectations, Analyst Ratings GlobeNewswire
Sep-20-18 12:56PM  Catalyst Pharmaceuticals Incs (NASDAQ:CPRX) Shift From Loss To Profit Simply Wall St.
08:03AM  Catalyst Pharmaceuticals to Participate in Two Upcoming Investor Conferences GlobeNewswire
Sep-06-18 11:39AM  Catalyst (CPRX) Up 16% Since Last Earnings Report: Can It Continue? Zacks
Aug-30-18 06:51PM  Healthcare Wiz Mitchell Blutt Bets Big on These 3 Biotech Stocks SmarterAnalyst
Aug-29-18 08:03AM  Catalyst Pharmaceuticals to Present at Rodman & Renshaws 20th Annual Global Investment Conference GlobeNewswire
Aug-22-18 07:03PM  Why Catalyst Pharmaceuticals (CPRX) Is a $6 Stock SmarterAnalyst
Aug-08-18 06:30AM  Catalyst Pharmaceuticals, Inc. to Host Earnings Call ACCESSWIRE
Aug-07-18 04:44PM  Catalyst: 2Q Earnings Snapshot Associated Press
04:20PM  Catalyst Pharmaceuticals Announces Second Quarter 2018 Financial Results and Provides Corporate Update GlobeNewswire
Aug-06-18 08:03AM  Catalyst Pharmaceuticals Expands Commercial Leadership Team GlobeNewswire
Aug-01-18 08:03AM  Catalyst Pharmaceuticals to Hold Second Quarter Financial Results and Corporate Update Conference Call and Webcast on Wednesday, August 8th, 2018 GlobeNewswire
07:30AM  New Research Coverage Highlights Ladder Capital, Gibraltar Industries, Norwegian Cruise Line, Wolverine World Wide, Catalyst Pharmaceuticals, and Radius Health Consolidated Revenues, Company Growth, and Expectations for 2018 GlobeNewswire
Jul-31-18 07:10AM  Complimentary Technical Snapshots on Akorn and Three More Generic Drugs Stocks ACCESSWIRE
Jun-28-18 07:50AM  Free Research Reports on Catalent and Three More Generic Drugs Stocks ACCESSWIRE
Jun-13-18 08:03AM  Catalyst Pharmaceuticals Appoints Daniel J. Brennan as Chief Commercial Officer GlobeNewswire
Jun-12-18 08:00AM  Opiant Pharmaceuticals Appoints Biotech and Pharmaceutical Industry Veteran Richard Daly to Board of Directors GlobeNewswire
May-31-18 08:03AM  Catalyst Pharmaceuticals to Present at the Jefferies 2018 Global Healthcare Conference GlobeNewswire
May-29-18 08:03AM  Catalyst Pharmaceuticals Announces FDA Acceptance of NDA and Priority Review Status for Firdapse® (Amifampridine Phosphate) for Lambert-Eaton Myasthenic Syndrome GlobeNewswire +8.59%
May-18-18 07:40AM  Wired News FDA Granted Approval to Eagle Pharmas Bendamustine Hydrochloride RTD Solution in a 500ml Admixture ACCESSWIRE
May-09-18 07:56PM  Catalyst: 1Q Earnings Snapshot Associated Press
04:13PM  Catalyst Pharmaceuticals Announces First Quarter 2018 Financial Results and Provides Corporate Update GlobeNewswire
May-02-18 08:03AM  Catalyst Pharmaceuticals to Hold First Quarter Financial Results and Corporate Update Conference Call and Webcast on Thursday, May 10th, 2018 GlobeNewswire
Apr-20-18 08:10AM  Report: Developing Opportunities within Clean Energy Fuels, Catalyst Pharmaceuticals, Qorvo, Brunswick, DCT Industrial Trust, and Radius Health Future Expectations, Projections Moving into 2018 GlobeNewswire
Apr-19-18 08:03AM  Catalyst Pharmaceuticals Announces Enrollment of First Patient in Phase 3 Trial of Firdapse® in MuSK Antibody Positive Myasthenia Gravis GlobeNewswire
Mar-29-18 02:20PM  Catalyst Pharmaceuticals files new drug application with FDA American City Business Journals
08:19AM  Catalyst Pharmaceuticals Announces Submission of New Drug Application for Firdapse® for Treatment of Lambert-Eaton Myasthenic Syndrome GlobeNewswire
Mar-14-18 04:20PM  Catalyst reports 4Q loss Associated Press
04:13PM  Catalyst Pharmaceuticals Announces Fourth Quarter and Year-End 2017 Financial Results and Provides Corporate Update GlobeNewswire
02:58PM  Catalyst Pharmaceuticals Inc (CPRX) and Achillion Pharmaceuticals, Inc. (ACHN) Among Five Cheap Healthcare Stocks To Buy Now Insider Monkey
09:50AM  When Will Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) Breakeven? Simply Wall St.
Mar-12-18 08:03AM  Catalyst Pharmaceuticals Announces Date and Time Change for Fourth Quarter and Year-End Financial Results Call and Webcast GlobeNewswire
Mar-08-18 08:04AM  Catalyst Pharmaceuticals to Hold Fourth Quarter and Year-End Financial Results Conference Call and Webcast on Thursday, March 15th, 2018 GlobeNewswire
Mar-05-18 09:35AM  What's in Store for Catalyst (CPRX) This Earnings Season? Zacks
Feb-28-18 08:03AM  Catalyst Pharmaceuticals Announces Its Continuing Support for Rare Disease Day 2018 GlobeNewswire
Feb-15-18 07:35AM  Detailed Research: Economic Perspectives on Carbo Ceramics, Consolidated Communications, Catalyst Pharmaceuticals, Office Depot, ImmunoGen, and Cedar Realty Trust What Drives Growth in Today's Competitive Landscape GlobeNewswire
Feb-12-18 08:03AM  Catalyst Pharmaceuticals Announces Plans to Resubmit New Drug Application for Firdapse® GlobeNewswire
Feb-07-18 08:03AM  Catalyst Pharmaceuticals to Present at Two Upcoming Investor Conferences GlobeNewswire
Dec-02-17 10:33AM  3 Drug Stocks That Soared This Week: Are They Buys? Motley Fool
Nov-30-17 02:07PM  Catalyst Pharmaceuticals, Inc. Announces Closing of Previously Announced Public Offering GlobeNewswire +8.31%
08:20AM  Analysis: Positioning to Benefit within Office Depot, ImmunoGen, Cedar Realty Trust, Carbo Ceramics, Consolidated Communications, and Catalyst Pharmaceuticals Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire
Nov-28-17 09:17AM  Catalyst Pharmaceuticals, Inc. Prices Previously Announced Public Offering of Common Stock Marketwired +10.25%
Nov-27-17 04:03PM  Catalyst Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock GlobeNewswire
06:30AM  Catalyst Pharmaceuticals Announces Positive Top-Line Results from Second Phase 3 Clinical Trial of Firdapse® in Patients with Lambert-Eaton Myasthenic Syndrome GlobeNewswire
Nov-21-17 08:03AM  Catalyst Pharmaceuticals Announces Phase 2 Study of Firdapse® in Ambulatory Patients with Spinal Muscular Atrophy (SMA) GlobeNewswire +6.86%
Nov-08-17 06:33PM  Catalyst reports 3Q loss Associated Press
04:41PM  Catalyst Pharmaceuticals Announces Third Quarter 2017 Financial Results and Provides Corporate Update GlobeNewswire
09:59AM  Have Investors Already Priced In Catalyst Pharmaceuticals Incs (CPRX) Growth? Simply Wall St.
Nov-06-17 10:33AM  What's in Store for Catalyst (CPRX) This Earnings Season? Zacks +5.70%
Nov-01-17 08:03AM  Catalyst Pharmaceuticals to Hold Third Quarter Financial Results Conference Call and Webcast on Thursday, November 9th, 2017 GlobeNewswire
Oct-31-17 08:03AM  Catalyst Pharmaceuticals Completes Enrollment in Second Phase 3 Trial of Firdapse® in Patients with Lambert-Eaton Myasthenic Syndrome GlobeNewswire +7.92%
Oct-16-17 08:03AM  Catalyst Pharmaceuticals to Present at 16th Annual BIO Investor Forum GlobeNewswire
Aug-30-17 08:03AM  Catalyst Pharmaceuticals Provides Update on the Status of its Firdapse Development Activities GlobeNewswire
Aug-10-17 06:40AM  Investor Network: Catalyst Pharmaceuticals, Inc. to Host Earnings Call ACCESSWIRE
Aug-09-17 10:00PM  Catalyst reports 2Q loss Associated Press
04:30PM  Catalyst Pharmaceuticals Announces Second Quarter 2017 Financial Results and Provides Corporate Update GlobeNewswire
Aug-01-17 08:03AM  Catalyst Pharmaceuticals to Hold Second Quarter Financial Results Conference Call and Webcast on Thursday, August 10th, 2017 GlobeNewswire -6.12%
Jul-12-17 08:10AM  Today's Research Reports on Trending Tickers: Nektar Therapeutics and Catalyst Pharmaceuticals Inc. Accesswire
Jun-26-17 08:03AM  Catalyst Pharmaceuticals Joins Russell 3000 Index GlobeNewswire
Jun-07-17 11:05AM  Three Junior Biotechs Ready to Run Investopedia
Jun-01-17 08:03AM  Catalyst Pharmaceuticals to Present at the Jefferies 2017 Healthcare Conference GlobeNewswire +5.19%
May-17-17 08:03AM  Catalyst Pharmaceuticals to Present at the Antiepileptic Drug and Device Trials XIV Symposium GlobeNewswire
May-12-17 11:26AM  Catalyst Pharmaceuticals Receives 2017 Beacon Council Award for Contributions in Life Sciences & Healthcare GlobeNewswire +5.98%
May-11-17 07:30AM  Investor Network: Catalyst Pharmaceuticals, Inc. to Host Earnings Call Accesswire
May-10-17 05:34PM  Catalyst reports 1Q loss Associated Press
04:35PM  Catalyst Pharmaceuticals Announces First Quarter 2017 Financial Results and Provides Corporate Update GlobeNewswire
11:25AM  Catalyst Pharmaceuticals Announces Poster Presentation of MuSK-MG clinical data at the 13th International Conference on Myasthenia Gravis and Related Disorders GlobeNewswire
May-02-17 06:40PM  What's in Store for Catalyst (CPRX) Stock in Q1 Earnings? Zacks
08:03AM  Catalyst Pharmaceuticals to Hold First Quarter Financial Results Conference Call and Webcast on Thursday, May 11th, 2017 GlobeNewswire
Mar-28-17 09:30AM  Catalyst Pharmaceuticals and ZIOPHARM Oncology Bounce Up On FDA Phase News Accesswire -5.47%
08:15AM  Catalyst Pharmaceuticals (CPRX) Jumps: Stock Gains 18.2%
Mar-24-17 01:04PM  CATALYST PHARMACEUTICALS, INC. Financials
Mar-23-17 09:47AM  Catalyst Pharma (CPRX) Focused on U.S. Approval for Firdapse
Mar-21-17 09:30AM  Financials of Aurinia Pharmaceuticals and Catalyst Pharmaceuticals are Getting Stability Accesswire
Mar-16-17 12:03PM  Catalyst Pharmaceuticals Inc (CPRX): Heres Whats Next Insider Monkey
Catalyst Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases. Its product candidates include Firdapse, a proprietary form of amifampridine phosphate that has completed Phase III clinical trials for the treatment of patients with lambert-eaton myasthenic syndrome; is in Phase III clinical trial to treat congenital myasthenic syndromes; and is in Phase III clinical trial for the treatment of anti-MuSK antibody positive myasthenia gravis, as well as is in Phase II clinical trial for patients with spinal muscular atrophy type 3. The company is also developing CPP-115, a gamma-aminobutyric acid aminotransferase inhibitor for the treatment of refractory infantile spasms; and CPP-109, a vigabatrin tablet. It has license agreements with Northwestern University, New York University and the Feinstein Institute for Medical Research, and BioMarin Pharmaceutical Inc. The company was formerly known as Catalyst Pharmaceutical Partners, Inc. and changed its name to Catalyst Pharmaceuticals, Inc. in May 2015. Catalyst Pharmaceuticals, Inc. was founded in 2002 and is based in Coral Gables, Florida.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
DENKHAUS DONALD ADirectorDec 27Buy1.9125,00047,750225,000Dec 28 12:29 PM
MCENANY PATRICK JPresident and CEODec 19Buy2.2420,00044,8004,737,693Dec 19 04:25 PM
DENKHAUS DONALD ADirectorDec 14Buy2.4860,000148,800200,000Dec 17 04:19 PM
O'Keeffe Charles BDirectorDec 14Buy2.5020,00050,000543,376Dec 14 04:50 PM
DENKHAUS DONALD ADirectorJun 08Buy3.4120,00068,200140,000Jun 11 08:48 AM
O'Keeffe Charles BDirectorJun 07Buy3.314,00013,222522,376Jun 07 03:35 PM
O'Keeffe Charles BDirectorJun 07Buy3.351,0003,352523,376Jun 08 04:26 PM
O'Keeffe Charles BDirectorJun 01Buy3.745,00018,680518,376Jun 01 04:21 PM
DENKHAUS DONALD ADirectorMay 30Buy3.7520,00075,000120,000May 31 11:57 AM
MCENANY PATRICK JPresident and CEOApr 03Buy2.2920,00045,8004,717,693Apr 03 04:13 PM